Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, Melbourne, Australia; Peter Doherty Institute of Infection and Immunity, Melbourne, Australia.
Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, CA, USA.
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10.
Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.
慢性乙型肝炎病毒 (HBV) 感染是与结核病、艾滋病病毒和疟疾等量齐观的全球性公共卫生挑战。国际消除乙型肝炎病毒联盟 (ICE-HBV) 是一个由专家组成的联盟,致力于加速发现慢性乙型肝炎的治愈方法。在与来自全球 50 多位科学家以及包括乙型肝炎病毒感染者在内的关键利益攸关方进行广泛协商后,我们确定了我们当前知识中的差距以及实现乙型肝炎病毒治愈所需的新战略和工具。我们认为,研究必须侧重于发现干预策略,这些策略将永久性地减少具有复制能力的感染细胞的数量,或永久性地使这些细胞中的共价闭合环状 DNA 失活,并将刺激乙型肝炎病毒特异性宿主免疫反应,从而模拟乙型肝炎病毒感染的自发解决。此外,还迫切需要建立乙型肝炎病毒标准试剂和方案的存储库,供全球所有乙型肝炎病毒研究人员使用。本立场文件中概述的乙型肝炎病毒治愈研究议程将对全球消除乙型肝炎病毒感染的目标做出重大贡献。